104 related articles for article (PubMed ID: 29921336)
1. In vitro treatment of Besnoitia besnoiti with the naphto-quinone buparvaquone results in marked inhibition of tachyzoite proliferation, mitochondrial alterations and rapid adaptation of tachyzoites to increased drug concentrations.
Müller J; Manser V; Hemphill A
Parasitology; 2019 Jan; 146(1):112-120. PubMed ID: 29921336
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of arylimidamides against Besnoitia besnoiti infection in Vero cells.
Cortes HC; Muller N; Boykin D; Stephens CE; Hemphill A
Parasitology; 2011 Apr; 138(5):583-92. PubMed ID: 21349220
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of nitro- and bromo-thiazolyl-salicylamide compounds (thiazolides) against Besnoitia besnoiti infection in Vero cells.
Cortes HC; Mueller N; Esposito M; Leitão A; Naguleswaran A; Hemphill A
Parasitology; 2007 Jul; 134(Pt 7):975-85. PubMed ID: 17306057
[TBL] [Abstract][Full Text] [Related]
4. Buparvaquone Induces Ultrastructural and Physiological Alterations Leading to Mitochondrial Dysfunction and Caspase-Independent Apoptotic Cell Death in Leishmania donovani.
Majhi S; Awasthi BP; Sharma RK; Mitra K
Microsc Microanal; 2024 Jul; 30(3):521-538. PubMed ID: 38709559
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
[TBL] [Abstract][Full Text] [Related]
6. Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.
Müller J; Aguado-Martinez A; Manser V; Balmer V; Winzer P; Ritler D; Hostettler I; Arranz-Solís D; Ortega-Mora L; Hemphill A
Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):16-25. PubMed ID: 25941626
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of commercially available anti-coccidials identifies diclazuril and decoquinate as potential therapeutic candidates against Besnoitia besnoiti infection.
Jiménez-Meléndez A; Rico-San Román L; Hemphill A; Balmer V; Ortega-Mora LM; Álvarez-García G
Vet Parasitol; 2018 Sep; 261():77-85. PubMed ID: 30253854
[TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites.
Jiménez-Meléndez A; Ojo KK; Wallace AM; Smith TR; Hemphill A; Balmer V; Regidor-Cerrillo J; Ortega-Mora LM; Hehl AB; Fan E; Maly DJ; Van Voorhis WC; Álvarez-García G
Int J Parasitol; 2017 Oct; 47(12):811-821. PubMed ID: 28899692
[TBL] [Abstract][Full Text] [Related]
9. A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone.
Tajeri S; Chattopadhyay D; Langsley G; Nijhof AM
PLoS One; 2024; 19(4):e0299002. PubMed ID: 38626086
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and plasma concentrations of two formulations of buparvaquone in cattle infected with East Coast fever (Theileria parva infection).
Muraguri GR; Ngumi PN; Wesonga D; Ndungu SG; Wanjohi JM; Bang K; Fox A; Dunne J; McHardy N
Res Vet Sci; 2006 Aug; 81(1):119-26. PubMed ID: 16289157
[TBL] [Abstract][Full Text] [Related]
11. Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis.
Smith L; Serrano DR; Mauger M; Bolás-Fernández F; Dea-Ayuela MA; Lalatsa A
Mol Pharm; 2018 Jul; 15(7):2570-2583. PubMed ID: 29762040
[TBL] [Abstract][Full Text] [Related]
12. Besnoitia besnoiti infection in cattle and mice: ultrastructural pathology in acute and chronic besnoitiosis.
Langenmayer MC; Gollnick NS; Scharr JC; Schares G; Herrmann DC; Majzoub-Altweck M; Hermanns W
Parasitol Res; 2015 Mar; 114(3):955-63. PubMed ID: 25576189
[TBL] [Abstract][Full Text] [Related]
13. Nanoliposomal Buparvaquone Immunomodulates Leishmania infantum-Infected Macrophages and Is Highly Effective in a Murine Model.
da Costa-Silva TA; Galisteo AJ; Lindoso JA; Barbosa LR; Tempone AG
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167544
[TBL] [Abstract][Full Text] [Related]
14. Besnoitia besnoiti lytic cycle in vitro and differences in invasion and intracellular proliferation among isolates.
Frey CF; Regidor-Cerrillo J; Marreros N; García-Lunar P; Gutiérrez-Expósito D; Schares G; Dubey JP; Gentile A; Jacquiet P; Shkap V; Cortes H; Ortega-Mora LM; Álvarez-García G
Parasit Vectors; 2016 Feb; 9():115. PubMed ID: 26928430
[TBL] [Abstract][Full Text] [Related]
15. Development of early tissue cysts and associated pathology of Besnoitia besnoiti in a naturally infected bull (Bos taurus) from South Africa.
Dubey JP; van Wilpe E; Blignaut DJ; Schares G; Williams JH
J Parasitol; 2013 Jun; 99(3):459-66. PubMed ID: 23327488
[TBL] [Abstract][Full Text] [Related]
16. Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis.
Lalatsa A; Statts L; Adriana de Jesus J; Adewusi O; Auxiliadora Dea-Ayuela M; Bolas-Fernandez F; Dalastra Laurenti M; Felipe Domingues Passero L; Serrano DR
Int J Pharm; 2020 Oct; 588():119734. PubMed ID: 32777535
[TBL] [Abstract][Full Text] [Related]
17. Experimental infections of rabbits with proliferative and latent stages of Besnoitia besnoiti.
Liénard E; Pop L; Prevot F; Grisez C; Mallet V; Raymond-Letron I; Bouhsira É; Franc M; Jacquiet P
Parasitol Res; 2015 Oct; 114(10):3815-26. PubMed ID: 26143866
[TBL] [Abstract][Full Text] [Related]
18. Activities of Endochin-Like Quinolones Against
Eberhard N; Balmer V; Müller J; Müller N; Winter R; Pou S; Nilsen A; Riscoe M; Francisco S; Leitao A; Doggett JS; Hemphill A
Front Vet Sci; 2020; 7():96. PubMed ID: 32161765
[TBL] [Abstract][Full Text] [Related]
19. Determination of the activity of sulfadiazine against Besnoitia darlingi tachyzoites in cultured cells.
Elsheikha HM; Mansfield LS
Parasitol Res; 2004 Aug; 93(5):423-6. PubMed ID: 15205942
[TBL] [Abstract][Full Text] [Related]
20. Antiparasitic Efficacy of Curcumin Against
Cervantes-Valencia ME; Hermosilla C; Alcalá-Canto Y; Tapia G; Taubert A; Silva LMR
Front Vet Sci; 2018; 5():333. PubMed ID: 30687723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
